HealthStream (HSTM) Competitors

Omnicell (NASDAQ:OMCL) and HealthStream (NASDAQ:HSTM) are both small-cap health care technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

Is OMCL or HSTM more profitable?

HealthStream has a net margin of 6.89% compared to Omnicell's net margin of 2.01%. HealthStream's return on equity of 5.70% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	2.01%	4.27%	2.44%
HealthStream	6.89%	5.70%	3.99%

Do analysts rate OMCL or HSTM?

Omnicell presently has a consensus target price of $46.71, indicating a potential upside of 53.41%. HealthStream has a consensus target price of $31.00, indicating a potential upside of 9.77%. Given Omnicell's higher possible upside, analysts clearly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Which has higher valuation and earnings, OMCL or HSTM?

HealthStream has lower revenue, but higher earnings than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.15B	1.22	$12.53M	$0.50	60.90
HealthStream	$295.21M	2.84	$20.01M	$0.67	42.15

Do insiders & institutionals hold more shares of OMCL or HSTM?

97.7% of Omnicell shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 2.5% of Omnicell shares are owned by company insiders. Comparatively, 20.5% of HealthStream shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has more risk and volatility, OMCL or HSTM?

Omnicell has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500.

Does the media prefer OMCL or HSTM?

In the previous week, Omnicell had 4 more articles in the media than HealthStream. MarketBeat recorded 7 mentions for Omnicell and 3 mentions for HealthStream. Omnicell's average media sentiment score of 1.29 beat HealthStream's score of 1.24 indicating that Omnicell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

HealthStream beats Omnicell on 9 of the 17 factors compared between the two stocks.